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Autophagy is commonly observed in metazoan
organisms during programmed cell death
(PCD), but its function in dying cells has been
unclear. We studied the role of autophagy in
embryonic cavitation, the earliest PCD process
in mammalian development. Embryoid bodies
(EBs) derived from cells lacking the autophagy
genes, atg5 or beclin 1, fail to cavitate. This de-
fect is due to persistence of cell corpses, rather
than impairment of PCD. Dying cells in autoph-
agy gene null EBs fail to express the ‘‘eat-me’’
signal, phosphatidylserine exposure, and se-
crete lower levels of the ‘‘come-get-me’’ signal,
lysophosphatidylcholine. These defects are as-
sociated with low levels of cellular ATP and are
reversed by treatment with the metabolic sub-
strate, methylpyruvate. Moreover, mice lacking
atg5 display a defect in apoptotic corpse en-
gulfment during embryonic development. We
conclude that autophagy contributes to dead-
cell clearance during PCD by a mechanism
that likely involves the generation of energy-
dependent engulfment signals.
INTRODUCTION
The lysosomal degradation pathway, autophagy, is active
during programmed cell death (PCD) in diverse taxa
(Bursch, 2001; Clarke, 1990; Levine and Yuan, 2005;
Lockshin and Zakeri, 2004; Schweichel and Merker,
1973). Autophagy is most pronounced in developmental
processes that involve massive cell elimination, such asembryogenesis, insect metamorphosis, glandular atresia,
and lumen formation. In such settings, it has often been
assumed that autophagy is a form of nonapoptotic PCD.
However, direct proof that autophagy is required for de-
velopmental cell death has been lacking, and alternative
hypotheses have been proposed to explain the presence
of autophagy in dying cells during development. One the-
ory is that autophagy may be activated in vivo as a cellular
protective mechanism (Levine, 2005) since autophagy
genes delay cell death in cultured mammalian cells sub-
jected to starvation or trophic factor withdrawal (Boya
et al., 2005; Lum et al., 2005a). Another theory is that au-
tophagy may be activated for cellular autolysis and self-
clearance during forms of developmental PCD accompa-
nied by insufficient availability of engulfment cells (Levine
and Yuan, 2005; Yuan et al., 2003). While these theories
are all biologically plausible, it is unknown why autophagy
is active during developmental PCD.
To evaluate the role of autophagy in PCD, we used
a mouse model of embryogenesis. In mammalian devel-
opment, the first wave of PCD occurs during cavitation
of the early embryo; the solid embryonic ectoderm un-
dergoes apoptosis to form the proamniotic cavity (Cou-
couvanis and Martin, 1995). This process can be mim-
icked in vitro by culturing mouse embryonic stem (ES)
cells in the absence of feeder cells and leukemia inhibitory
factor (LIF) (Poirier et al., 1991). In these conditions, ES
cells form undifferentiated cell aggregates that develop
into simple embryoid bodies (EBs), containing an outer
layer of endodermal cells and an inner solid core of ecto-
dermal cells. The inner ectodermal cells of the simple EBs
undergo PCD to form cystic EBs.
We examined the effect of null mutations in autophagy
genes atg5 and beclin 1 on the ability of ES cells to form
cystic EBs. Atg5 is an acceptor molecule for the ubiqui-
tin-like molecule Atg12, and the proper conjugation of
Atg5 with Atg12 is required for the elongation of theCell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 931
autophagic membrane (Mizushima et al., 2001). Beclin 1 is
the mammalian ortholog of yeast Atg6 and interacts with
Class III PI3K (Vps34) to mediate the localization of other
autophagy proteins to the preautophagosomalmembrane
(Kihara et al., 2001; Liang et al., 1999). ES cells lacking
either atg5 or beclin 1 are defective in autophagosome
formation (Mizushima et al., 2001; Yue et al., 2003). There-
fore, by culturing these ES cells in conditions that mimic
in vivo embryogenesis, we could examine the role of
autophagy in PCD during mammalian morphogenesis.
Our results indicate that autophagy genes are dispens-
able for PCD but are essential for the generation of engulf-
ment signals required for the phagocytic removal of dying
cells during development.
RESULTS
Autophagy Gene-Deficient ES Cells Display a Defect
in Formation of Cavitated EBs
To evaluate the role of autophagy in embryonic cavitation,
we studied themorphology of EBs derived frompreviously
described ES cells lacking two different autophagy genes,
atg5, and beclin 1, their isogenic wild-type counterparts,
and a clone of atg5/ ES cells stably transformed with
atg5 (Mizushima et al., 2001; Yue et al., 2003). We con-
firmed the lack of Atg5 and Beclin 1 expression in these
cells by immunoblot analysis (Figures 1A and 1B).
The atg5/ and beclin 1/ ES cells formed simple EBs
similarly to isogenic wild-type control ES cells. However,
we observed striking differences in the ability of wild-
type and autophagy gene null simple EBs to form cystic
EBs (Figures 1C–1E). Beginning at day 10, cavities were
commonly observed in wild-type EBs, but only rarely ob-
served in atg5/ or beclin 1/ EBs. By day 20, nearly
80% of atg5+/+ EBs and nearly 70% of beclin 1+/+ EBs
were cystic, as compared to less than 10% of atg5/
EBs and less than 20% of beclin 1/ EBs (p < 0.0001
for both atg5+/+ versus atg5/ and beclin 1+/+ versus
beclin 1/; t test). The atg5-restored atg5/ EBs had
an intermediate phenotype (Figures 1C and 1E), consis-
tent with their lower levels of Atg5 protein expression
than wild-type EBs (Figure 1A). When cultured in the pres-
ence of LIF, wild-type ES cells still formed cystic EBs (al-
beit, as previously reported (Murray and Edgar, 2001) at
a reduced frequency compared to EBs grown in the ab-
sence of LIF) whereas atg5/ and beclin 1/ EBs were
severely defective in the formation of cystic EBs (Fig-
ure S1A in the Supplemental Data available with this article
online). Based on these data, we conclude that two differ-
ent autophagy genes, atg5 and beclin 1, are required for
the normal cavitation of mouse EBs.
Autophagy Gene-Deficient ES Cells Undergo
Apoptotic Cell Death and Visceral Endoderm
Differentiation and Express Cavitation Signals
during EB Development
To determine whether the cavitation defect observed in
atg5/ and beclin 1/ EBs results from impaired apopto-932 Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc.tic cell death, we performed TUNEL staining at serial time
points in development (Figures 2A, 2B, and Figure S2A).
Compared toatg5+/+EBs,atg5/EBshaveamild increase
in TUNEL-positive cells at day 3 (p = 0.048, t test) and
a greater increase at day 6 (p < 0.0001, t test). The number
of TUNEL-positive cells in atg5/ EBs remained elevated
at days 10, 14, and 20, whereas the numbers in atg5+/+
and atg5-restored atg5/ EBs peaked at day 10, and de-
clined at days 14 and day 20 in association with central
clearing of the EBs. In the atg5/ EBs, since nearly 80%
of the cells were dead by day 6, the persistent high levels
of TUNEL-positive cells until day 20 most likely reflects a
failure to clear these dead cells. Indeed, upon higher power
imagingat this timepoint, thecentral regionsofatg5/EBs
are almost all filled with cellular debris (Figure S3).
Although there was an increase in TUNEL-positive cells
in atg5/EBs at early timepoints, wedid not detect a sim-
ilar increase in beclin 1/ EBs versus beclin 1+/+ EBs at
days 3 and 6 (Figure S2A). This suggests that autophagy
gene deficiency does not invariably result in accelerated
cell death during EB development. However, similar to
the defect in atg5/ EBs, we also observed a defect in
the clearance of TUNEL-positive cells in beclin 1/ EBs.
After reaching a peak at day 10 in EBs of both genotypes,
the numbers of TUNEL-positive cells gradually declined
in beclin 1+/+ EBs but remained persistently elevated in
beclin 1/ EBs (Figure S2A). At day 20, beclin 1/ EBs,
like atg5/EBs, were filledwith cellular debris (Figure S3).
Thus, deletion of two different autophagy genes does not
impair PCD during EB development but does block the
clearance of apoptotic cells.
To further characterize the nature and kinetics of cell
death in autophagy null EBs, wemeasured caspase activ-
ity using a DEVD cleavage assay (Figures 2C and S2B).
Caspase activity peaked at day 6 in EBs of all genotypes.
No significant differences in caspase activity were ob-
served between atg5/ and atg5+/+ at any time point ex-
amined (Figure 2C) or between beclin 1/ and beclin 1+/+
EBs except for a mild increase in beclin 1+/+ EBs at day 6
(p = 0.036, t test) (Figure S2B). In addition, cell death in
atg5/ and beclin 1/EBs was accompanied by similar
levels of active caspase 3 and similar apoptotic features
to those observed in control EBs (data not shown). Since
the mitochondrial apoptosis-inducing factor, AIF, is es-
sential for PCD during EB cavitation (Joza et al., 2001),
we also measured aif mRNA levels by semiquantitative
RT-PCR in wild-type and autophagy gene-deficient EBs
(Figures 2D and S2C). Aif gene expression was similar in
atg5/ versus atg5+/+ EBs (Figure 2D) and in beclin 1/
versus beclin 1+/+ EBs (Figure S2C) at days 3, 6, and 10
in development. Taken together, our results indicate that
atg5/ and beclin 1/ EBs cells undergo PCD during
EB formation that is similar to PCD observed in wild-
type EBs with respect to TUNEL positivity, caspase activ-
ity, caspase 3 activation, cellular morphology, and aif
mRNA expression. Thus, the failure of EBs derived from
atg5/ and beclin 1/ ES cells to cavitate cannot be
attributed to a lack of apoptotic cell death.
Figure 1. Atg5 and beclin 1 Are Essential for EB Cavitation
(A and B) Western blot analysis of ES cell lines using an anti-Atg5 antibody (A) or anti-Beclin 1 antibody (B).
(C and D) Percentage of cystic EBs at serial time points after culture of indicated ES cell lines. EBs with complete cavitation of the inner ectodermal
layer were classified as cystic. Results represent mean value ± SEM from three independent experiments.
(E) Representative light micrographs of H&E-stained cells that were used for quantitative analysis in (C). Scale bars represent 200 mm. Beclin 1+/+ EBs
appeared similar to atg5+/+ EBs and beclin 1/ EBs appeared similar to atg5/ EBs (data not shown).Based on previous studies of EB cavitation using differ-
ent targeted mutant ES cells, EB cavitation is thought to
be accompanied by differentiation of primitive endoderm
into visceral endoderm (VE), basementmembrane deposi-
tion, secretion of BMP signals, death of the inner ectoder-
mal core, and differentiation of the outer ectodermal layer
into pseudostratified columnar epithelium (Li et al.,
2003b). While our data above indicates that death of the
inner ectodermal core occurs normally in autophagy null
EBs, we also sought to assess other aspects of EB differ-
entiation that have been previously associated with cavi-tation. Using RT-PCR, we found that the expression of
three specific VE molecular markers, Hnf4, Afp, and Ttr
(Coucouvanis and Martin, 1999), displayed similar kinetic
patterns and similar magnitudes of increase in atg5/
versus atg5+/+EBs (Figure 2D). Compared to beclin 1+/+
EBs, beclin 1/ EBs have slightly higher levels of expres-
sion of Hnf4 (at day 6 and 10), of Afp (at day 6), and of Ttr
(at day 3) (Figure S2C). While the basis for this increase is
unclear, these data nonetheless demonstrate that VE dif-
ferentiation markers are expressed in beclin 1/ EBs at
least as highly as in isogenic control EBs. Furthermore,Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 933
Figure 2. Atg5 Is Not Essential for Apoptotic Cell Death, Cavitation Signals, or VE Differentiation during EB Development
(A) TUNEL staining to detect apoptotic cells in EBs of indicated genotype. Scale bars represent 200 mm.
(B) Quantitation of percentage of TUNEL-positive cells in EBs of indicated genotype.
(C) Caspase activity in EBs of indicated genotypes. Y axis represents the total fluorescence detected in 50 pooled EBs. For (B) and (C), results
represent the mean value ± SEM from three independent experiments.934 Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc.
Figure 3. Autophagy Is Deficient in atg5/ EBs and Active during Wild-Type EB Development
(A) Conversion of LC3-I to LC3-II during EB development. Homogenates from 60 EBs per time point per genotype were pooled and analyzed by
immunoblotting using an anti-LC3 antibody.
(B) Autophagosome formation in ectodermal cells of atg5+/+ EBs indicated by GFP-LC3 punctate staining. Arrows denote representative autopha-
gosomes. Scale bars represent 10 mm.at the ultrastructural level, atg5/ and beclin 1/
EBs displayed morphologic changes indicative of normal
endoderm differentiation, including the formation of a
dome-shaped, vacuolated cells with microvilli at the
periphery of the EBs (Figure S4).
In addition, we found that two signals which have been
shown to regulate both VE differentiation and ectodermal
cavitation of EBs, BMP2 and BMP4 (Coucouvanis and
Martin, 1999), are expressed with similar kinetics and at
similar levels in atg5/ versus atg5+/+EBs (Figure 2D)
and in beclin 1/ versus beclin 1+/+ EBs (Figure S2C). To-
gether, these data demonstrate that autophagy null EBs
are not defective in VE differentiation or expression of
the cavitation signals, BMP2 and BMP4. Since previously
described mutants in EB cavitation all demonstrate de-
fects in cell death, VE differentiation, and/or BMP signal-
ing (Li et al., 2003b), our findings point to a unique role
for autophagy genes in EB cavitation.
Autophagy Activation during EB Development
To evalulate whether autophagy is activated during EB de-
velopment, we performed immunoblot analysis of endog-enous LC3 processing in atg5+/+, atg5/, and atg5-re-
stored atg5/ EBs (Figure 3A). LC3 is the mammalian
ortholog of the yeast autophagy protein, Atg8, and is
widely used as a marker of mammalian autophagy (Ka-
beya et al., 2000). During autophagy induction, cytosolic
LC3-I undergoes proteolytic cleavage and lipidation to
form the membrane-bound LC3-II. In atg5/ EBs, LC3-
II was absent at all time points, indicating that the atg5
null mutation abolishes autophagy in ES cells during EB
development and confirming that autophagy is not re-
quired for PCD, VE differentiation, or upregulation of
BMP2 or BMP4 gene expression. In atg5+/+ and atg5-re-
stored atg5/ EBs, LC3-II was detected at all time points,
with the highest ratios of LC3-II/LC3-I observed early in
development (day 3 and day 6), when maximal amounts
of PCD are occurring. The activation of autophagy during
EB cavitation is not due to withdrawal of the growth factor
LIF, since similar levels of LC3-I to LC3-II conversion were
observed in both atg5+/+ and beclin 1+/+ EBs cultured in
the presence or absence of LIF (Figure S1B).
To evaluate whether autophagy is active in the inner ec-
todermal cells that undergo PCD during EB development,(D) Semiquantitative RT-PCR analysis of gene expression of apoptosis-inducing factor (Aif), cavitation and VE differentiation signals (BMP2 and
BMP4), and VE-specific molecular markers (Hnf4, Afp, and Ttr). Similar results were observed in three independent experiments.Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 935
Figure 4. Engulfment of Dead Cells Is Impaired in atg5/ and beclin 1/ EBs
(A) Representative EMs of atg5+/+ and atg5/ EBs at day 6 of development. For each genotype, the boxed region in photomicrograph of semithin
section was used for EM analysis. Black arrows denote representative dead cell remnants that have been engulfed. Scale bars for semithin section
photomicrographs represent 200 mm; scale bars for EMs represent 2 mm. Similar phenotypes were observed in beclin 1/ and beclin 1+/+ EBs (data
not shown).
(B and C) Quantification of the percentage of engulfed dead cells in atg5/ and atg5+/+ EBs (B) and beclin 1/ and beclin 1+/+ EBs (C) at day 6 in
development. Between 100–200 dead cells from 10 randomly distributed grid squares of the inner ecotermal core were scored per EB. Results rep-
resent the mean value ± SEM from 3–6 EBs per experimental group. For (A)–(C), ‘‘+MP’’ indicates that EBs were treated with 10 mM MP at day 4 of
development.we performed light microscopic analysis of wild-type
atg5+/+ EBs stably transformed with the fluorescent au-
tophagy marker, GFP-LC3 (Mizushima et al., 2004).
GFP-LC3 redistributes from a diffuse cytoplasmic pattern
to form punctate structures that label preautophagosomal
and autophagosomal membranes when autophagy is
stimulated. In GFP-LC3-expressing EBs, the majority of
inner ectodermal cells had punctate GFP-LC3 staining at
day 3 (Figure 3B, left panel). By day 6, fewer cells were
present in the inner ectoderm that expressed detectable
GFP-LC3, an observation that may reflect the fewer num-
ber of viable cells present in ectoderm at this time (see
image of TUNEL staining in atg5+/+ EBs on day 6 in
Figure 2A). Nonetheless, amongst residual cells express-
ing GFP-LC3, the majority contained punctate staining,
indicating the presence of autophagy (Figure 3B, right
panel). Taken together, our data indicate that autophagy
is active during PCD of the inner ectodermal cells, but is
dispensable for its occurrence.936 Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc.Autophagy Gene-Deficient Dead EB Cells
Are Not Engulfed
In both atg5/ and beclin 1/ EBs, TUNEL-positive cells
persisted in the center of the EBs for more than 20 days in
culture (Figures 2A, 2B, and S2A; data not shown). This
suggested that autophagy genes are essential for the
clearance of dead cells during EB development. To further
evaluate this hypothesis, we examined the ultrastructure
of the inner ectodermal regions of EBs at day 6 of develop-
ment (Figures 4A and S5; data not shown). In atg5+/+ and
beclin 1+/+ EBs, there was morphological evidence of en-
gulfment of apoptotic cell corpses by healthy cells in the
inner ectoderm. In contrast, in atg5/ and beclin 1/
EBs, the inner ectodermal layer consisted primarily of
dead cells, and there was an almost complete lack of en-
gulfment of apoptotic corpses. Even in regions at the pe-
riphery of the inner ectodermal core where dead cells were
in close juxtaposition to healthy cells (see images 2 and 3
for atg5/ EBs in Figure 4A), very few apoptotic corpses
were visualized inside healthy cells, suggesting that fac-
tors other than availability of healthy cells contribute to de-
fective dead cell engulfment. By quantitative EM analysis,
40%–50% of dead cells in atg5+/+ and beclin 1+/+ EBs
were engulfed inside healthy neighboring cells as com-
pared to 0%–10% in atg5/ and beclin 1/ EBs (p =
0.002 for atg5+/+ versus atg5/ EBs, p = 0.003 for beclin
1+/+ versus beclin 1/ EBs, t test) (Figures 4B and 4C).
Thus, there is a marked defect in apoptotic corpse engulf-
ment in both atg5/ and beclin 1/ EBs.
Autophagy Gene-Deficient EB Cells Fail to Generate
the ‘‘Eat-Me’’ Signal of Phosphatidylserine Exposure
on the Outer Membrane Surface
The engulfment of apoptotic cells by phagocytes depends
on signals from the apoptotic cell, including markers on
the apoptotic cell surface (referred to as ‘‘eat-me’’ signals)
and signals secreted by the apoptotic cell (referred to as
‘‘come-get-me’’ signals) (Grimsley and Ravichandran,
2003; Lauber et al., 2004). Given the engulfment defect
in atg5/ and beclin 1/ EBs, we hypothesized that
autophagy genes may be essential for the generation of
eat-me and/or come-get-me signals in apoptotic cells.
The best-characterized eat-me signal is the exposure of
phosphatidylserine (PS) on the outer leaflet of the plasma
membrane, a process that can be detected by staining
with the PS-specific probe, annexin V (Grimsley and Rav-
ichandran, 2003). We compared the outer membrane
leaflet exposure of PS in atg5/ and atg5+/+ EBs and in
beclin 1/ and beclin 1+/+ EBs by adding biotinylated
annexin V to live EB cultures which were then fixed,
sectioned, and stained with HRP-avidin (Figure 5A).
The pattern of annexin V staining in the inner ectodermal
cells of atg5+/+ and beclin 1+/+ EBs (Figures 5A and S6)
was identical to that observed for TUNEL staining
(Figure 2A and data not shown), indicating that apoptotic
wild-type EB cells expose PS at their outer membrane
surface. In contrast, almost no annexin V staining was
observed in the inner ectodermal cells of atg5/ or
beclin 1/ EBs (Figures 5A and S6), despite the presence
of TUNEL positivity, caspase 3 activation, and ultrastruc-
tural characteristics of apoptosis. The percentage of
annexin V-positive EBs was 70%–80% in wild-type EBs
whereas only 8%–12% of atg5/ and beclin 1/ EBs
were annexin V-positive (p < 0.0001 for atg5+/+ versus
atg5/ EBs, p = 0.009 for beclin 1+/+ versus beclin 1/
EBs, t test) (Figure 5B). Therefore, two different auto-
phagy genes, beclin 1 and atg5, that act at different steps
in the autophagy pathway, are essential for the generation
of a critical engulfment signal, PS exposure, that occurs
in PCD during embryonic cavitation. This requirement for
autophagy genes in PS exposure is not observed in single
ES cell cultures treated with apoptosis-inducing agents
such as etoposide, mitomycin C, and staurosporine
(Figure S7) suggesting that unique mechanisms exist for
regulating PS exposure in three-dimensional tissue
models.Autophagy Gene-Deficient EBs Secrete Lower
Levels of the ‘‘Come-Get-Me’’ Signal,
Lysophosphatidylcholine
The release of lysophosphatidylcholine (LPC) from apo-
ptotic cells functions as a critical come-get-me signal
and chemoattractant for phagocyte recruitment (Lauber
et al., 2003). Using electrospray ionization mass spec-
trometry (ESI-MS), we analyzed the culture media of EBs
for three forms of LPC, 16:0 LPC, 18:0 LPC, and 18:1
LPC, at both day 3 and day 6 in development (Figures
5C and 5D). The secretion of these three forms of LPC
was significantly lower in atg5/ EBs versus atg5+/+
EBs (p = 0.003 for day 3, p = 0.007 for day 6, paired t
test) and in beclin 1/ versus beclin 1+/+ EBs (p = 0.004
for day 3, p = 0.001 for day 6, paired t test). Thus, autoph-
agy null EBs are deficient in the secretion of an important
chemoattractant factor, LPC, which is involved in trigger-
ing the efficient removal of apoptotic corpses. This defect
in secretion of chemoattractant signals may explain the
absence of healthy phagocytic cells in the inner ectoder-
mal core of autophagy null EBs.
Autophagy Gene-Deficient EB Cells Have Decreased
ATP Production that Is Reversed by Treatment with
the Tricarboxylic Acid Substrate, Methylpyruvate
One function of autophagy is to generate amino acids and
fatty acids that are utilized by the tricarboxylic acid (TCA)
cycle for ATP production (Lum et al., 2005b). We postu-
lated that this ATP-generating function of autophagy in dy-
ing cells may be required for the expression of apoptotic
corpse engulfment signals. To begin to investigate this
hypothesis, we measured ATP levels in atg5/ and
beclin 1/ EBs and wild-type control EBs. As predicted,
ATP levels were significantly lower at both day 3 and
day 6 in development in atg5/ and beclin 1/ EBs
than in wild-type EBs (p < 0.0001 for day 3 and p =
0.016 for day 6 for atg5/ versus atg5+/+ EBs, and p <
0.0001 for day 3 and p = 0.018 for day 6 for beclin 1/
versus beclin 1+/+ EBs, t test) (Figures 6A and 6B). The
decreased ATP levels in atg5/ and beclin 1/ EBs
demonstrates a role for autophagy genes in maintaining
cellular energy homeostasis during development.
We determined whether the defect in ATP production in
atg5/ and beclin 1/ EBs could be reversed by treating
theEBswith a cell-permeable formof pyruvate,methylpyr-
uvate (MP), that serves as an alternative metabolic sub-
strate for the TCA cycle. MP has been used previously to
restore cellular bioenergetics in autophagy-deficient cells
deprived of trophic factor support (Lumet al., 2005b). Sim-
ilarly, we found that one dose of 10 mM MP restored ATP
production in both atg5/ and beclin 1/ EBs to levels
that were equivalent to those observed in untreated wild-
type EBs (Figures 6A and 6B). This pattern was observed
both when EBs were treated with MP on day 2 and ATP
production was measured on day 3 (Figure 6A) and when
EBs were treated with MP on day 4 and ATP production
was measured on day 6 of development (Figure 6B). MP
had no effect on ATP levels in atg5+/+ or beclin 1+/+ EBs,Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 937
Figure 5. Atg5/ and beclin 1/ EBs Fail to Expose PS at the Outer Membrane Surface
(A) Annexin V staining to detect PS at the outer membrane surface in EBs of indicated genotype at day 6 of development. Scale bars represent 50 mm.
See Figure S6 for higher-power images.938 Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc.
indicating that it specifically reverses the defect in auto-
phagy null EBs and does not act as stimulator of ATP pro-
duction in autophagy-competent cells (Figures 6Aand6B).
Further, MP did not alter the levels of cell death as mea-
sured by quantitative TUNEL analyses in either wild-type
or autophagy null EBs (Figures 6C and 6D). This suggests
that MP restores normal levels of ATP production in au-
tophagy-deficient EBs by increasing cellular production
of ATP rather than by increasing cell viability.
MP Reverses the Defects in Apoptotic Cell
Engulfment, PS Exposure, and LPC Secretion
in Autophagy Gene-Deficient EBs
Next, we evaluated the effects of restoring ATP production
by MP treatment on apoptotic cell engulfment, PS expo-
sure, LPC secretion, and early stages of cavity formation
in atg5/ and beclin 1/ EBs. Upon EM analysis, MP
treatment (administered at day 4) had no discernible
effects on the ultrastructure of wild-type EBs at day 6 of
development (Figure 4A for atg5+/+; data not shown for
beclin 1+/+). In contrast, MP treatment significantly altered
the ultrastructure of atg5/ and beclin 1/ EBs. Unlike
untreated autophagy gene-deficient EBs, MP-treated
atg5/ and beclin 1/ EBs contained a pattern of dead
cells similar to that observed in wild-type EBs, with an
inner ectodermal core composed of a mix of healthy and
dead cells (Figure 4A for atg5+/+; data not shown for
beclin 1+/+). Moreover, upon MP treatment, the percent-
age of engulfed dead cells increased in atg5/ and
beclin 1/ EBs to levels that were similar to those
observed in wild-type EBs (Figures 4B and 4C). Thus,
MP treatment reverses the defect in apoptotic corpse en-
gulfment in autophagy gene-deficient EBs.
MP treatment also reversed defects in PS exposure and
LPC secretion in atg5/ and beclin 1/ EBs. MP had no
effect on the percentage of wild-type EBs that demon-
strated annexin V staining, but increased the percentage
of atg5/ and beclin 1/ EBs with annexin V staining
to levels comparable to those observed in wild-type con-
trols (Figure 5B). Similarly, MP treatment did not signifi-
cantly alter levels of LPC secretion in wild-type EBs, but
increased LPC secretion in atg5/ and beclin 1/ EBs
to levels similar to those observed in wild-type EBs. This
effect was seen both at day 3 (untreated atg5/ versus
MP-treated atg5/, p = 0.002; untreated beclin 1/
versus MP-treated beclin 1/, p = 0.004, paired t test)
(Figure 5C) and day 6 of development (untreated
atg5/ versus MP-treated atg5/, p = 0.001; untreated
beclin 1/ versus MP-treated beclin 1/, p = 0.002,
paired t test) (Figure 5D).
To determine whether the reversal of defects in ATP
production, PS exposure, LPC exposure and apoptotic
corpse engulfment by MP treatment in autophagy-deficient EBs affected EB cavitation, we quantitated the
percentage of untreated and MP-treated wild-type and
autophagy-deficient EBs with partial cavitation at day 6
in development (Figures 6E–6G). Partial cavitation of the
inner ectodermal core is observed in approximately 30%
of wild-type EBs by day 6 in development (Figures 6E–
6G). We chose this time point for measuring the effects
of MP on partial cavitation (rather than on complete cystic
cavitation at later time points in development) since pro-
longed MP treatment was toxic to EBs of all genotypes.
Similar to the defect in the formation of cystic EBs at day
20 in development, both atg5/ (Figure 6F) and beclin
1/ (Figure 6G) EBs displayed marked defects in partial
cavitation at day 6 in development (p < 0.0001 for both
atg5/ versus atg5+/+ and beclin 1/ versus beclin 1+/+,
t test). MP treatment did not alter the percentage of wild-
type EBs with partial cavitation but markedly increased
the percentage of autophagy gene-deficient EBs with par-
tial cavitation (p < 0.0001 for both untreated atg5/ versus
MP-treated atg5/ and untreated beclin 1/ versus MP-
treated beclin 1/, t test). The percentages of MP-treated
atg5/ EBs and beclin 1/ EBs with partial cavitation
were similar to those observed in the wild-type EBs (Fig-
ures 6F and 6G). Thus, MP treatment not only reverses
the defect in apoptotic corpse engulfment in autophagy
gene-deficient EBs but also the defect in cavitation.
Atg5/ Is Required In Vivo for Apoptotic
Corpse Clearance
Our findings demonstrate an essential role for autophagy
genes in apoptotic corpse clearance during PCD in an
in vitro EB cavitation model. To evaluate whether auto-
phagy genes also play a role a similar role in vivo, we per-
formed studies in atg5/ mice. As previously reported
(Kuma et al., 2004), atg5/ mice are born at normal
Mendelian ratios, but die within the first 24 hr after birth.
Mutant mice harboring defects in apoptotic cell engulf-
ment (e.g., PS receptor knockout mice) also die during
this time period but display defects in apoptotic corpse
clearance in lung, retina, and brain (Li et al., 2003a). There-
fore, we evaluated whether atg5/ mice also display
defects in apoptotic corpse clearance during embryonic
development in two representative tissues, lung and ret-
ina. In the photoreceptor and ganglion cell layers of the
retina, there was a 7-8 fold increase in the number of
TUNEL-positive, apoptotic cells in atg5/ mice as com-
pared to wild-type littermates at day E18.5 (Figures 7A
and 7B) and at day E15.5 and E19.5 (data not shown)
(p < 0.0001, t test). In parallel with the increased accumu-
lation of TUNEL-positive cells, we also observed an in-
creased number of inflammatory cells (predominantly lym-
phocytes and less frequently neutrophils) (Figure S8A). In
lung, we observed a 2-3 fold increase in the number of(B) Quantitation of percentage of EBs with positive annexin V staining. Results represent the mean value ± SEM from three independent experiments.
(C and D) ESI-MS detection of 16:0, 18:0, and 18:1 LPC in EB culture supernatants at day 3 (C) and day 6 (D) of development. ‘‘Total LPC’’ refers to the
sum of each of these three independent measurements. Results represent the mean values ± SEM from three independent experiments. In (A)–(D),
‘‘+MP’’ indicates that EBs were treated with 10 mM MP at day 4 (A, B, and D) or at day 2 (C) in development.Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 939
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apoptotic cells in atg5/ mice as compared to atg5+/+
mice at day E19.5 (Figures 7E and 7F) and at day E15.5
and E18.5 (data not shown) (p < 0.0001, t test). At day
E19.5,weobservedneutrophils (FigureS8B) and the accu-
mulation of necrotic cell debris (Figure 7G, right panel) in
the lungs of atg5/ but not atg5+/+ mice. To examine
whether the increased accumulation of TUNEL-positive
and inflammatory cells in the retina and lungs of atg5/
mice is associated with a defect in apoptotic cell clear-
ance, we performed EM analyses of day E18.5 retina (Fig-
ures 7C and 7D) and day E19.5 lung (Figures 7G and 7H).
More than 70% of apoptotic corpses were engulfed in
both wild-type atg5+/+ retina (Figure 7D) and lung (Fig-
ure 7H). In contrast, less than 25% of dead cell corpses
wereengulfed in the retina (Figure7D) and lungs (Figure7H)
of atg5/mice (p = 0.005 for retina and p = 0.014 for lung,
t test). These findings suggest that the increased number
of apoptotic cells in atg5/ retina and lung is, at least in
part, due to defective dead cell clearance.
DISCUSSION
Autophagy Is Required for the Phagocytic Removal
of Cell Corpses during PCD
Our findings identify a novel role for autophagy in PCD.
Using an in vitro model of mammalian embryonic morpho-
genesis, EB development, we found that two different au-
tophagy genes, atg5 and beclin 1, are required for the
clearance of dead cells during EB cavitation. In the ab-
sence of autophagy genes, the amount of cell death in
the inner ectodermal cells is at least equivalent to that ob-
served in wild-type EBs. Yet, the dead cells fail to be re-
moved and consequently, cavitation is impaired. Based
upon ultrastructural analyses of atg5 and beclin 1 null
EBs, this defect in cell corpse removal appears to be
due to absent engulfment by phagocytic cells. Moreover,
ultrastructural analyses of atg5/ embryos reveal a defect
in engulfment of apoptotic corpses in mouse retina and
lungs. Thus, autophagy genes are required for the phago-
cytic removal of corpses during PCD both in the in vitro EB
model as well as in vivo during mouse development.
Autophagy Genes Are Necessary for the Generation
of Eat-Me and Come-Get-Me Signals Required for
Engulfment of Apoptotic Cells
The efficient removal of apoptotic corpses involves evolu-
tionarily conserved processes which include the genera-tion of eat-me signals on the surface of apoptotic cells,
the secretion of come-get-me signals by apoptotic cells,
the migration of phagocytes to sites of cell death, and the
phagoyctic recognition and uptake of the apoptotic cells
(Grimsley and Ravichandran, 2003; Lauber et al., 2004;
Ravichandran, 2003). Using EBs derived from ES cells
lacking atg5 and beclin 1, we found that both autophagy
genes are necessary for two of these processes. The
dying cells in both autophagy gene-deficient EBs fail to
expose PS on their outer membrane leaflet, and therefore
lack expression of a critical eat-me signal that is essential
for apoptotic cell engulfment. In addition, autophagy
gene-deficient EBs secrete lower levels of the come-
get-me signal, LPC, than their wild-type counterparts.
Since both PS exposure and LPC secretion are essen-
tial for engulfment of apoptotic cells (Grimsley and Ravi-
chandran, 2003; Ravichandran, 2003), either of these de-
fects alone is sufficient to account for the lack of apoptotic
corpse clearance in autophagy-deficient EBs. However,
we did not specifically address whether defects in the
generation of other engulfment signals also contribute to
the lack of engulfment of dying cells in atg5-deficient
and beclin 1-deficient EBs. In addition, we did not address
whether intact autophagy is required for the proper
phagocytic function of engulfment cells. Indeed, since ef-
ficient engulfment requires PS exposure not only on the
dying cells but also on the healthy phagocytes (Marguet
et al., 1999), it is possible that phagocytic function might
also be impaired in autophagy gene deficient EBs that
lack detectable evidence of PS exposure during devel-
opment. Nonetheless, our data provide evidence that
autophagy can function in a cell autonomous manner in
dying cells to facilitate apoptotic corpse clearance. This
mechanism most likely involves, but is not limited to,
autophagy-dependent redistribution of PS to the outer
membrane leaflet and autophagy-dependent release of
chemotactic phospholipids.
Of note, the cell surface exposure of PS during apopto-
sis is phylogenetically conserved (van den Eijnde et al.,
1998). This conservation has led to the assumption that
PS may represent a primordial factor involved in the
phagocytic removal of apoptotic cells during develop-
ment. Therefore, the requirement that we identified for au-
tophagy genes in PS exposure in cavitating mouse EBs
may also provide insights into mechanisms of cell death
elimination in other metazoans. For example, it will be in-
teresting to determine whether defective PS exposureFigure 6. Deficient ATP Production in atg5/ and beclin 1/ EBs and Reversal of ATP Deficiency and Cavitation Defects in
atg5/ and beclin 1/ EBs by MP Treatment
(A and B) ATP levels at day 3 (A) or day 6 (B) of development in EBs of indicated genotype.
(C and D) Quantitation of percentage of TUNEL-positive cells in atg5+/+ or atg5/ EBs (C) and beclin 1+/+ or beclin 1/ EBs (D) at day 6 of devel-
opment.
(E) H&E-stained sections of EBs of indicated genotype at day 6 of development. Arrows indicate representative EBs with partial cavitation. Scale bars
represent 200 mm.
(F and G) Quantitation of percentage of atg5+/+ or atg5/ EBs (F) or beclin 1+/+ or beclin 1/ EBs (G) with partial cavitation at day 6 of development.
EBs with any central clearing were classified as partially cavitated.
For (A)–(G), EBs were either untreated (MP) or treated with 10 mMMP (+MP). In (A), EBs were treated with 10 mMMP at day 2, and in (B)–(G), EBs
were treated with 10 mM MP at day 4 of development. Results represent the mean value ± SEM from three independent experiments.Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 941
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and defective engulfment contribute to the excess num-
bers of embryonic corpses observed in C. elegans with
a null mutation in the beclin 1 orthologe, bec-1 (Takacs-
Vellai et al., 2005).
Autophagy Genes May Contribute to the Generation
of Engulfment Signals in Apoptotic Cells by
Maintaining Cellular ATP Production
One of the important functions of autophagy is to maintain
cellular bioenergetics in cells subjected to nutrient depri-
vation and potentially other forms of stress (Lum et al.,
2005b). The efficient removal of apoptotic corpses re-
quires several signaling events that involve the dynamic
distribution of lipid species across the membrane bilayer.
The ATP binding cassette, ABC1 in mammalian cells, and
its ortholog, CED-7 in C. elegans, are both required for the
efficient engulfment of apoptotic cells and for many pro-
cesses related to membrane lipid dynamics, including
PS exposure and release of membrane phospholipids
(Hamon et al., 2000; Lauber et al., 2004). Although we
are not aware of any studies directly assessing the effects
of cellular ATP levels in dying cells on ABC1 function, we
hypothesized that the lack of autophagy-dependent cellu-
lar ATP production might contribute to the defects that we
observed in autophagy null EBs, including the lack of PS
exposure, the decreased levels of LPC secretion, and
the defect in apoptotic cell engulfment.
Our results indicate that restoration of normal ATP levels
in autophagy null EBs is associatedwith reversal of the de-
fects in PS exposure, LPC secretion, and apoptotic cell
engulfment. These observations strongly suggest that
the mechanism by which autophagy contributes to apo-
ptotic cell corpse clearance involves the generation of
ATP-dependent engulfment signals. Previous work has
demonstrated that autophagy is essential for maintaining
cellular bioenergetics during growth factor deprivation
(Lum et al., 2005b). Our findings point to a novel biological
function of autophagy-dependent ATP production. In con-
trast to previouswork in which autophagy-dependent ATP
production was shown to promote cell survival (Lum et al.,
2005b), our findings suggest that autophagy-dependent
ATP production promotes the successful completion of
the final phase of the apoptotic program, the efficient
clearance of apoptotic cells.
Implications for the Role of Autophagy
in Development and PCD
The role of autophagy-dependent apoptotic corpse clear-
ance inmouseEBcavitationmay overlapwith a similar rolein other PCD processes involved in the morphogenesis of
multicellular organisms, including cavitation of the embry-
onic inner cell mass, formation of hollow organs, genera-
tion of glandular structures and sexual organs, and sculpt-
ing of digits, the palate and the eyes (Jacobson et al.,
1997). Indeed, a previous study showed that lumen forma-
tion in an in vitromorphogenesis model of mammary gland
development involves both activation of apoptosis and au-
tophagy pathways, although the precise mechanism by
which autophagy contributed to cell elimination was not
explored (Mills et al., 2004). Autophagy may also be re-
quired for the phagocytic removal of dead cells in other de-
velopmental settings where apoptosis and autophagy are
known to be active simultaneously, such as salivary gland
regression inDrosophila (Baehrecke, 2003), aswell as dur-
ing developmental events characterized primarily by ‘‘au-
tophagic PCD’’ (Clarke, 1990; Lockshin and Zakeri, 2004).
Based upon our findings with mouse EBs lacking the
autophagy genes, atg5 and beclin 1, one would predict
that autophagy null mutant mouse embryos would be de-
fective in formation of the proamniotic cavity. Indeed, we
have observed that beclin 1/ embryos have an increase
of embryonic ectodermal TUNEL-positive cells and fail to
form proamniotic cavities (data not shown); this phenotype
is highly consistent with our observations with in vitro EBs
derived from both autophagy-deficient beclin 1/ and
atg5/ ES cells. A puzzling question is why, given the
failure of both atg5/ and beclin 1/ ES cells to undergo
EB cavitation, only beclin 1/ embryos but not atg5/
embryos display a similar defect in development (i.e., in for-
mation of the proamniotic cavity). It is possible that beclin 1
has an additional function other than autophagy (which
atg5 lacks) that is required for proamniotic cavity forma-
tion in vivo. However, given that the phenotypes of the
beclin 1/ and atg5/ EBs are identical with respect to
a lack of ectodermal cavitation, we favor the hypothesis
that as-of-yet identified factors can compensate in vivo
during early development for the lack of atg5 but not for
the lack of beclin 1.
Although atg5/ mice lack defects in formation of the
proamniotic cavity, our studies demonstrate an in vivo
role for atg5 in the clearance of apoptotic corpses during
PCD. Similar to the phenotype reported in mice lacking
the PS receptor (Li et al., 2003a), we found an excess in
apoptotic corpses in the lungs and retina of atg5/
mice at days E15.5, E18.5, and E19.5. In both of these tis-
sues, ultrastructural analyses revealed amarked decrease
in the engulfment of apoptotic corpses in mice lacking
atg5. Thus, the essential role of autophagy genes inFigure 7. Atg5/ Embryos Have Deficient Clearance of Apoptotic Cell Corpses during Development
(A and E) Representative images of TUNEL staining to detect apoptotic cells in the retina of day E18.5 embryonicmice (A) and in the lungs of day E19.5
embryonic mice (E). Scale bars represent 50 mm. (B and F) Quantitation of percentage of TUNEL-positive cells in retina of day E18.5 mice (B) and in
lungs of day E19.5 mice (F). (C and G) Representative EMs from retinal photoreceptor layer of day E18.5 mice (C) and from lung sections of day E19.5
mice (G). Scale bar represents 2 mm. (D and H) Quantification of the percentage of dead cells that are engulfed in retina of day E18.5 mice (D) and in
lungs of day E19.5 mice (H). For (A) and (E), black arrow denotes apoptotic cells. For (C) and (G), black arrow denotes apoptotic corpses that are
engulfed by a phagocytic cell. Arrowhead denotes dead cell that is not engulfed with necrotic features. For (B), (D), (F,) and (H), results represent
mean value ± SEM of sections from five mice per genotype.Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc. 943
promoting the clearance of apoptotic cells is not limited to
the in vitro EB cavitation model; at least one autophagy
gene, atg5, is required for the engulfment of apoptotic
cells during the morphogenesis of specific organs in late
embryonic development.
In addition to morphogenesis, the efficient removal of
apoptotic cells is crucial for tissue homeostasis in multi-
cellular organisms and for the prevention of unwanted in-
flammatory responses that are triggered by secondary
(postapoptotic) necrosis. In retina and lungs from embry-
onic mice lacking atg5, we observed an increased
number of inflammatory cells, indicating that the lack of
efficient apoptotic corpse engulfment in autophagy-
deficient animals is associated with abnormal inflamma-
tory responses during developmental PCD. Interestingly,
features of apoptosis and autophagy coexist not only
during developmental PCD, but also during the cell death
that occurs in vivo in neurodegenerative diseases, in in-
fectious diseases, and in chemotherapy-treated cancer
cells. Thus, our findings that autophagy genes are re-
quired for the efficient elimination of apoptotic cells
may also have relevance for understanding the role of
autophagy in these settings. The activation of autophagy
in cells destined to die by apoptosis may serve to ensure
the efficient clearance of apoptotic cells and the preven-
tion of detrimental inflammatory responses both during
normal development and during exposure to pathological
stimuli.
EXPERIMENTAL PROCEDURES
ES Cell and EB Formation Assay
Atg5+/+, atg5/ (clone A11), and atg5-restored atg5/ (clone WT13)
ES cells (Mizushima et al., 2001) and GFP-LC3-expressing wild-type
(atg5+/+) ES cells (Mizushima et al., 2004) were provided by Noboru
Mizushima. Beclin 1+/+ and beclin 1/ ES cells (Yue et al., 2003)
were provided by Dr. Nathaniel Heintz. EBs were formed by culturing
ES cells in suspension in the absence of LIF as described (Ng et al.,
2004). EB cultures were treated with 10 mM MP (Sigma) at day 2
in development (for measurement of ATP production on day 3 of
development) or at day 4 in development (for measurement of
ATP production, apoptotic corpse engulfment, annexin V staining,
LPC secretion, TUNEL staining, and partial cavitation on day 6 of
development).
Mice
Atg5/ mice (Mizushima et al., 2004) were provided by Noboru Miz-
ushima. Mice aged E15.5, E18.5, or E19.5 were used for histopatho-
logical and EM analyses of lung and retina. All animal procedures
were performed in accordance with guidelines established by the
Institutional Animal Care and Use Committee.
Histological Analyses
Cultured EBs were collected after 3, 6, 10, 14, and 20 days, fixed in 4%
paraformaldehyde, and paraffin-embedded sections were used for
H&E analysis, TUNEL staining, and Annexin V detection. For detection
of apoptosis, TUNEL staining was performed using ApoTag Peroxi-
dase In Situ Apoptosis Detection Kit (Intergen Co.). For detection of
PS translocation, EBs were cultured with Annexin V in calcium binding
buffer for 3 hr prior to fixation, and Annexin V was detected in paraffin
sections using a commercially available TACS Annexin V-Biotin
Kit (Trevigen Inc.). For histopathological analyses, quantification was944 Cell 128, 931–946, March 9, 2007 ª2007 Elsevier Inc.performed by an observer blinded to genotype using 60 EBs per
experimental group (except for quantitation of percentage of TUNEL-
positive cells, which used 15 randomly selected EBs per experimental
group).
For analyses of atg5/ and atg5+/+ mouse lung and retina, mice
were sacrificed at days E15.5, E18.5, or E19.5, tissues were fixed by
immersion in 4% paraformaldehyde, and paraffin-embedded sections
were used for H&E analysis and TUNEL staining.
Measurement of Caspase Activity
Fifty pooled EBs per genotype at day 3, 6, 10, 14, and 20 were
collected, lysed, and assayed for caspase activity according to the
manufacturer’s instructions using an EnzChek Caspase-3 Assay Kit
(Molecular Probes).
Measurement of LPC
Lipids were prepared from the culture supernatant of approximately
200 EBs in the presence or absence of 10 mM MP (Sigma) at the
indicated time points. 16:0, 18:0 and 18:1 LPC was analyzed by ESI-
MS as described (Xiao et al., 2001) using a QTRAP 4000 mass
spectrometer.
Confocal Microscopic Analyses
GFP-LC3-expressing atg5+/+ EBs were fixed with 4% paraformalde-
hyde and cryosections were prepared. GFP fluorescence was visual-
ized with a Zeiss LSM51 confocal microscope using the 488 nm line
of the argon laser.
EM Analyses
Atg5+/+ and atg5/ and beclin 1/ and beclin 1+/+ EBs were fixed
overnight with 2.5% glutaraldehyde in 0.1 M (pH 7.4) cacodylate
buffer. Atg5/ and atg5+/+ mouse lungs and eyes were fixed in
4% paraformaldehyde and 1% glutaraldehyde in 0.1M cacodylate
buffer. Samples were prepared, visualized by transmission EM as
described (Liang et al., 1999) and the percentage of engulfed
corpses was determined. Corpses were defined as condensed
chromatin-containing structures with early apoptotic morphology,
late apoptotic morphology, or necrotic-like features. Corpses within
intact plasma membranes of healthy cells were classified as ‘‘en-
gulfed’’ and corpses outside of intact healthy cells were classified
as ‘‘not engulfed’’.
ATP Assays
ATP levels were measured from 60 pooled EBs in the presence or ab-
sence of 10 mM MP by the luciferin/luciferase method using an ATP
Bioluminescence Assay Kit HSII (Roche Diagnostics) and a FLUOstar
OPTIMA BMG+ Labtech Microplate Luminometer according to the
manufacturer’s instructions.
RT-PCR, Immunoblot Analyses, and ES Cell Annexin V Staining
Please see Supplemental Experimental Procedures for methods of
RT-PCR, immunoblot analyses, and ES cell Annexin V staining.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and eight figures and can be found with
this article online at http://www.cell.com/cgi/content/full/128/5/931/
DC1/.
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